ArticleThe Journal of clinical investigation2019

Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis.

Patricia Santofimia-Castaño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.